Carasent ASA

CARA

NO0010123060

Carasent ASA is a Norway-based technology Company. The strategy of Carasent is to develop and expand digitalization that helps customers to meet challenges in providing efficient and qualitative health care services. The Company provides its customers with cloud based medical record software solutions and a broad ecosystem of integrated services, in a range of healthcare segments. Carasent focuses on businesses that develop entrepreneurial and e-health solutions. Operating business activities in the Group can be categorized into six different categories; Software as a Service (SaaS), Add-on services, Consulting, License, maintenance and other. All services are delivered to the health care sector.

Sector

IT Services & Consulting

Calendar

2024-07-11 - Q2 2024 Earnings Call

More about the company

Income Statement Evolution

More financial data

Ratings for Carasent ASA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.75 NOK

Average target price

25.5 NOK

Spread / Average Target

+72.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other IT Services & Consulting

	1st Jan change	Capi.
CARASENT ASA	+35.62%	97M
ACCENTURE PLC	-12.72%	197B
IBM	+2.36%	169B
TATA CONSULTANCY SERVICES LTD.	+1.55%	166B
AUTOMATIC DATA PROCESSING, INC.	+5.20%	101B
RELX PLC	+4.86%	76.87B
CROWDSTRIKE HOLDINGS, INC.	+14.32%	71.98B
INFOSYS LIMITED	-6.77%	71.09B
SNOWFLAKE INC.	-24.28%	51.76B
HCL TECHNOLOGIES LIMITED	+2.60%	48.08B

Other IT Services & Consulting

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-04-25 am EDT			5-day change	1st Jan Change
15 ^NOK	+1.69%		+40.85%	+35.62%

Apr. 24	Carasent ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 24	Transcript : Carasent ASA, Q1 2024 Earnings Call, Apr 24, 2024

Carasent ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Transcript : Carasent ASA, Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
Carasent ASA Announces Changes to Its Board	Apr. 17	CI
Tranche Update on Carasent ASA (OB:CARA)'s Equity Buyback Plan announced on September 25, 2023.	Feb. 15	CI
Carasent ASA Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Carasent ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Transcript : Carasent ASA, Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Carasent to Divest Confrere Brand to Compodium International	Feb. 05	MT
Carasent ASA Announces Staffan Hanstorp Resigns as A Member of the Board of Directors	Nov. 30	CI
Carasent Wins Contract to Deliver Electronic Health Record System to Volvat in Norway	Nov. 22	MT
Carasent ASA Approves Dividend	Nov. 14	CI
Transcript : Carasent ASA - Analyst/Investor Day	Nov. 07
Tranche Update on Carasent ASA (OB:CARA)'s Equity Buyback Plan announced on September 25, 2023.	23-10-26	CI
Carasent ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Transcript : Carasent ASA, Q3 2023 Earnings Call, Oct 26, 2023	23-10-26
Carasent Kicks Off Share Buyback	23-09-25	MT
Carasent ASA (OB:CARA) commences an Equity Buyback Plan for 79,540,907 shares, representing 9.99% of its issued share capital, under the authorization approved on May 3, 2023.	23-09-24	CI
Transcript : Carasent ASA, Q2 2023 Earnings Call, Jul 14, 2023	23-07-14
Carasent ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-13	CI
Carasent Seeks M&A	23-05-04	CI
Transcript : Carasent ASA, Q1 2023 Earnings Call, May 04, 2023	23-05-04
Carasent ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-03	CI
Transcript : Carasent ASA - Special Call	23-04-24
Carasent Ends Key Product Development for Norway, Plans Cost Savings Program	23-04-24	MT
Carasent ASA Announces Step Down of Terje Rogne as Board Director	23-04-03	CI